Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignancies Multiple”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Not applicableUnknownNCT05096533
What this trial is testing

The Application Value of Artificial Intelligence in MRI Precision Diagnosis and Treatment of Bladder Cancer

Who this might be right for
Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 150
Testing effectiveness (Phase 2)UnknownNCT05669586
What this trial is testing

Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer

Who this might be right for
Lung CancerOrganoid
Affiliated Hospital of Jiangnan University 50
Not applicableStudy completedNCT01006070
What this trial is testing

Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine

Who this might be right for
Multiple Myeloma
University of California, San Francisco 50
Testing effectiveness (Phase 2)Study completedNCT05383170
What this trial is testing

Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

Who this might be right for
Advanced Head and Neck Squamous Cell CarcinomaAdvanced Breast CancerAdvanced Melanoma
Cytovation AS 6
Not applicableNot Yet RecruitingNCT07693894
What this trial is testing

DISARM Clinical Study B: Evaluation of Innovative Ovarian Cancer Biomarker Assays

Who this might be right for
Ovarian Cancer
National and Kapodistrian University of Athens 2,080
Early research (Phase 1)Ended earlyNCT04893551
What this trial is testing

Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants

Who this might be right for
Ovarian Neoplasms
BerGenBio ASA 16
Testing effectiveness (Phase 2)WithdrawnNCT00706953
What this trial is testing

Bortezomib and Pegylated Liposomal Doxorubicin in Patients With Relapsed Multiple Myeloma Previously Treated With Bortezomib

Who this might be right for
Multiple Myeloma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Not applicableLooking for participantsNCT07519837
What this trial is testing

Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics

Who this might be right for
Cachexia; Cancer; Sarcopenia
China Medical University, China 1,000
Not applicableStudy completedNCT01127373
What this trial is testing

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 116
Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Post-approval studies (Phase 4)UnknownNCT03150602
What this trial is testing

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Who this might be right for
Peripheral T Cell LymphomaProgression, Disease
Taiwan Mundipharma Pharmaceuticals Ltd. 22
Testing effectiveness (Phase 2)UnknownNCT02248402
What this trial is testing

Autologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Chonnam National University Hospital 15
Not applicableStudy completedNCT04364256
What this trial is testing

Muscle Stimulation for Physical Function During Stem Cell Transplant

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant
VA Office of Research and Development 46
Early research (Phase 1)Study completedNCT00926731
What this trial is testing

Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)

Who this might be right for
Acute Myeloid Leukemia
AstraZeneca 4
Not applicableLooking for participantsNCT03218345
What this trial is testing

EUS-guided RFA for Pancreatic Neoplasms

Who this might be right for
Pancreatic Neoplasms
Chinese University of Hong Kong 30
Testing effectiveness (Phase 2)Study completedNCT02858895
What this trial is testing

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Who this might be right for
GlioblastomaGrade IV AstrocytomaGlioblastoma Multiforme+1 more
Medicenna Therapeutics, Inc. 47
Post-approval studies (Phase 4)WithdrawnNCT05183139
What this trial is testing

In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Takeda
Testing effectiveness (Phase 2)Active Not RecruitingNCT04933539
What this trial is testing

Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 14
Large-scale testing (Phase 3)Study completedNCT03739684
What this trial is testing

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Recurrent+1 more
Progenics Pharmaceuticals, Inc. 208
Next Page